IBDEI0AY ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10959,1,4,0)
 ;;=4^E10.39
 ;;^UTILITY(U,$J,358.3,10959,2)
 ;;=^5002603
 ;;^UTILITY(U,$J,358.3,10960,0)
 ;;=E10.321^^53^605^3
 ;;^UTILITY(U,$J,358.3,10960,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10960,1,3,0)
 ;;=3^DM Type 1 w/ Mild Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10960,1,4,0)
 ;;=4^E10.321
 ;;^UTILITY(U,$J,358.3,10960,2)
 ;;=^5002594
 ;;^UTILITY(U,$J,358.3,10961,0)
 ;;=E10.329^^53^605^4
 ;;^UTILITY(U,$J,358.3,10961,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10961,1,3,0)
 ;;=3^DM Type 1 w/ Mild Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10961,1,4,0)
 ;;=4^E10.329
 ;;^UTILITY(U,$J,358.3,10961,2)
 ;;=^5002595
 ;;^UTILITY(U,$J,358.3,10962,0)
 ;;=E10.331^^53^605^5
 ;;^UTILITY(U,$J,358.3,10962,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10962,1,3,0)
 ;;=3^DM Type 1 w/ Moderate Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10962,1,4,0)
 ;;=4^E10.331
 ;;^UTILITY(U,$J,358.3,10962,2)
 ;;=^5002596
 ;;^UTILITY(U,$J,358.3,10963,0)
 ;;=E10.339^^53^605^6
 ;;^UTILITY(U,$J,358.3,10963,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10963,1,3,0)
 ;;=3^DM Type 1 w/ Moderate Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10963,1,4,0)
 ;;=4^E10.339
 ;;^UTILITY(U,$J,358.3,10963,2)
 ;;=^5002597
 ;;^UTILITY(U,$J,358.3,10964,0)
 ;;=E10.341^^53^605^9
 ;;^UTILITY(U,$J,358.3,10964,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10964,1,3,0)
 ;;=3^DM Type 1 w/ Severe Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10964,1,4,0)
 ;;=4^E10.341
 ;;^UTILITY(U,$J,358.3,10964,2)
 ;;=^5002598
 ;;^UTILITY(U,$J,358.3,10965,0)
 ;;=E10.349^^53^605^10
 ;;^UTILITY(U,$J,358.3,10965,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10965,1,3,0)
 ;;=3^DM Type 1 w/ Severe Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10965,1,4,0)
 ;;=4^E10.349
 ;;^UTILITY(U,$J,358.3,10965,2)
 ;;=^5002599
 ;;^UTILITY(U,$J,358.3,10966,0)
 ;;=E10.351^^53^605^7
 ;;^UTILITY(U,$J,358.3,10966,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10966,1,3,0)
 ;;=3^DM Type 1 w/ Prolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10966,1,4,0)
 ;;=4^E10.351
 ;;^UTILITY(U,$J,358.3,10966,2)
 ;;=^5002600
 ;;^UTILITY(U,$J,358.3,10967,0)
 ;;=E10.359^^53^605^8
 ;;^UTILITY(U,$J,358.3,10967,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10967,1,3,0)
 ;;=3^DM Type 1 w/ Prolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10967,1,4,0)
 ;;=4^E10.359
 ;;^UTILITY(U,$J,358.3,10967,2)
 ;;=^5002601
 ;;^UTILITY(U,$J,358.3,10968,0)
 ;;=E08.311^^53^605^39
 ;;^UTILITY(U,$J,358.3,10968,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10968,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10968,1,4,0)
 ;;=4^E08.311
 ;;^UTILITY(U,$J,358.3,10968,2)
 ;;=^5002510
 ;;^UTILITY(U,$J,358.3,10969,0)
 ;;=E08.319^^53^605^40
 ;;^UTILITY(U,$J,358.3,10969,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10969,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10969,1,4,0)
 ;;=4^E08.319
 ;;^UTILITY(U,$J,358.3,10969,2)
 ;;=^5002511
 ;;^UTILITY(U,$J,358.3,10970,0)
 ;;=E08.321^^53^605^41
 ;;^UTILITY(U,$J,358.3,10970,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10970,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Mild Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10970,1,4,0)
 ;;=4^E08.321
 ;;^UTILITY(U,$J,358.3,10970,2)
 ;;=^5002512
 ;;^UTILITY(U,$J,358.3,10971,0)
 ;;=E08.329^^53^605^42
 ;;^UTILITY(U,$J,358.3,10971,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10971,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Mild Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10971,1,4,0)
 ;;=4^E08.329
 ;;^UTILITY(U,$J,358.3,10971,2)
 ;;=^5002513
 ;;^UTILITY(U,$J,358.3,10972,0)
 ;;=E08.331^^53^605^43
 ;;^UTILITY(U,$J,358.3,10972,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10972,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Moderate Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10972,1,4,0)
 ;;=4^E08.331
 ;;^UTILITY(U,$J,358.3,10972,2)
 ;;=^5002514
 ;;^UTILITY(U,$J,358.3,10973,0)
 ;;=E08.339^^53^605^44
 ;;^UTILITY(U,$J,358.3,10973,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10973,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Moderate Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10973,1,4,0)
 ;;=4^E08.339
 ;;^UTILITY(U,$J,358.3,10973,2)
 ;;=^5002515
 ;;^UTILITY(U,$J,358.3,10974,0)
 ;;=E08.341^^53^605^47
 ;;^UTILITY(U,$J,358.3,10974,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10974,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Severe Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10974,1,4,0)
 ;;=4^E08.341
 ;;^UTILITY(U,$J,358.3,10974,2)
 ;;=^5002516
 ;;^UTILITY(U,$J,358.3,10975,0)
 ;;=E08.349^^53^605^48
 ;;^UTILITY(U,$J,358.3,10975,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10975,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Severe Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10975,1,4,0)
 ;;=4^E08.349
 ;;^UTILITY(U,$J,358.3,10975,2)
 ;;=^5002517
 ;;^UTILITY(U,$J,358.3,10976,0)
 ;;=E09.311^^53^605^37
 ;;^UTILITY(U,$J,358.3,10976,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10976,1,3,0)
 ;;=3^Diab d/t Drug/Chem w/ Unspec Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10976,1,4,0)
 ;;=4^E09.311
 ;;^UTILITY(U,$J,358.3,10976,2)
 ;;=^5002552
 ;;^UTILITY(U,$J,358.3,10977,0)
 ;;=E09.319^^53^605^38
 ;;^UTILITY(U,$J,358.3,10977,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10977,1,3,0)
 ;;=3^Diab d/t Drug/Chem w/ Unspec Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10977,1,4,0)
 ;;=4^E09.319
 ;;^UTILITY(U,$J,358.3,10977,2)
 ;;=^5002553
 ;;^UTILITY(U,$J,358.3,10978,0)
 ;;=E09.321^^53^605^29
 ;;^UTILITY(U,$J,358.3,10978,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10978,1,3,0)
 ;;=3^Diab d/t Drug/Chem w/ Mild Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10978,1,4,0)
 ;;=4^E09.321
 ;;^UTILITY(U,$J,358.3,10978,2)
 ;;=^5002554
 ;;^UTILITY(U,$J,358.3,10979,0)
 ;;=E09.329^^53^605^30
 ;;^UTILITY(U,$J,358.3,10979,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10979,1,3,0)
 ;;=3^Diab d/t Drug/Chem w/ Mild Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10979,1,4,0)
 ;;=4^E09.329
 ;;^UTILITY(U,$J,358.3,10979,2)
 ;;=^5002555
 ;;^UTILITY(U,$J,358.3,10980,0)
 ;;=E09.351^^53^605^33
 ;;^UTILITY(U,$J,358.3,10980,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10980,1,3,0)
 ;;=3^Diab d/t Drug/Chem w/ Prolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10980,1,4,0)
 ;;=4^E09.351
 ;;^UTILITY(U,$J,358.3,10980,2)
 ;;=^5002560
 ;;^UTILITY(U,$J,358.3,10981,0)
 ;;=E09.359^^53^605^34
 ;;^UTILITY(U,$J,358.3,10981,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10981,1,3,0)
 ;;=3^Diab d/t Drug/Chem w/ Prolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10981,1,4,0)
 ;;=4^E09.359
 ;;^UTILITY(U,$J,358.3,10981,2)
 ;;=^5002561
 ;;^UTILITY(U,$J,358.3,10982,0)
 ;;=E08.351^^53^605^45
 ;;^UTILITY(U,$J,358.3,10982,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10982,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Prolif Diab Rtnop w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10982,1,4,0)
 ;;=4^E08.351
 ;;^UTILITY(U,$J,358.3,10982,2)
 ;;=^5002518
 ;;^UTILITY(U,$J,358.3,10983,0)
 ;;=E08.359^^53^605^46
 ;;^UTILITY(U,$J,358.3,10983,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10983,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Prolif Diab Rtnop w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10983,1,4,0)
 ;;=4^E08.359
 ;;^UTILITY(U,$J,358.3,10983,2)
 ;;=^5002519
 ;;^UTILITY(U,$J,358.3,10984,0)
 ;;=E13.351^^53^605^27
 ;;^UTILITY(U,$J,358.3,10984,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10984,1,3,0)
 ;;=3^DM w/ Prolif Diab Retinopathy w/ Macular Edema
